Abstract:Graphene and its derivatives are emerging as attractive materials for biomedical applications, including antibacterial, gene delivery, contrast imaging, and anticancer therapy applications. It is of fundamental importance to study the cytotoxicity and biocompatibility of these materials as well as how they interact with the immune system. The present study was conducted to assess the immunotoxicity of graphene oxide (GO) and vanillin-functionalized GO (V-rGO) on THP-1 cells, a human acute monocytic leukemia cell line. The synthesized GO and V-rGO were characterized by using various analytical techniques. Various concentrations of GO and V-rGO showed toxic effects on THP-1 cells such as the loss of cell viability and proliferation in a dose-dependent manner. Cytotoxicity was further demonstrated as an increased level of lactate dehydrogenase (LDH), loss of mitochondrial membrane potential (MMP), decreased level of ATP content, and cell death. Increased levels of reactive oxygen species (ROS) and lipid peroxidation caused redox imbalance in THP-1 cells, leading to increased levels of malondialdehyde (MDA) and decreased levels of anti-oxidants such as glutathione (GSH), glutathione peroxidase (GPX), super oxide dismutase (SOD), and catalase (CAT). Increased generation of ROS and reduced MMP with simultaneous increases in the expression of pro-apoptotic genes and downregulation of anti-apoptotic genes suggest that the mitochondria-mediated pathway is involved in GO and V-rGO-induced apoptosis. Apoptosis was induced consistently with the significant DNA damage caused by increased levels of 8-oxo-dG and upregulation of various key DNA-regulating genes in THP-1 cells, indicating that GO and V-rGO induce cell death through oxidative stress. As a result of these events, GO and V-rGO stimulated the secretion of various cytokines and chemokines, indicating that the graphene materials induced potent inflammatory responses to THP-1 cells. The harshness of V-rGO in all assays tested occurred because of better charge transfer, various carbon to oxygen ratios, and chemical compositions in the rGO. Overall, these findings suggest that it is essential to better understand the parameters governing GO and functionalized GO in immunotoxicity and inflammation. Rational design of safe GO-based formulations for various applications, including nanomedicine, may result in the development of risk management methods for people exposed to graphene and graphene family materials, as these nanoparticles can be used as delivery agents in various biomedical applications.

Graphene Oxide Attenuates Toxicity of Amyloid‐β Aggregates in Yeast by Promoting Disassembly and Boosting Cellular Stress Response (Adv. Funct. Mater. 45/2023)

Molecular Dynamics Simulations Reveal the Mechanism of Graphene Oxide Nanosheet Inhibition of Aβ1-42 Peptide Aggregation.

Graphene Oxide Quantum Dot Alters Amyloidogenicity of Hen Egg White Lysozyme via Modulation of Protein Surface Character

Dependence of Graphene Oxide (GO) Toxicity on Oxidation Level, Elemental Composition, and Size

Mechanistic Insights into the Inhibition and Size Effects of Graphene Oxide Nanosheets on the Aggregation of an Amyloid-Β Peptide Fragment

In Vitro Toxicity Evaluation of Graphene Oxide on A549 Cells.

Graphene Oxide, a Prominent Nanocarrier to Reduce the Toxicity of Alzheimer's Proteins: A Revolution in Treatment

Graphene Oxide Disrupted Mitochondrial Homeostasis Through Inducing Intracellular Redox Deviation and Autophagy-Lysosomal Network Dysfunction in SH-SY5Y Cells

Protein Corona-Mediated Mitigation of Cytotoxicity of Graphene Oxide.

Effect of graphene oxide on conformation and activity of catalase

Graphene Oxide Induces P62/sqstm-Dependent Apoptosis Through the Impairment of Autophagic Flux and Lysosomal Dysfunction in PC12 Cells.

The Cytotoxic Effectiveness of Thiourea-Reduced Graphene Oxide on Human Lung Cancer Cells and Fungi

Cytotoxicity of Graphene: Recent Advances and Future Perspective.

Graphene oxide nanosheets disrupt lipid composition, Ca2+ homeostasis and synaptic transmission in primary cortical neurons

Graphene oxide upregulates the homeostatic functions of primary astrocytes and modulates astrocyte-to-neuron communication

Next-Generation Sequencing Reveals Differential Responses to Acute versus Long-Term Exposures to Graphene Oxide in Human Lung Cells

Graphene Oxide Significantly Inhibits Cell Growth at Sublethal Concentrations by Causing Extracellular Iron Deficiency.

Antibacterial Activity of Graphite, Graphite Oxide, Graphene Oxide, and Reduced Graphene Oxide: Membrane and Oxidative Stress.

Inhibition of TORC1 Pathway in Saccharomyces Cerevisiae to Induce Autophagy Using Graphene Oxide

The Effect of Water Hardness on the Toxicity of Graphene Oxide to Bacteria in Synthetic Surface Waters.

Differential Immunomodulatory Effect of Graphene Oxide and Vanillin-Functionalized Graphene Oxide Nanoparticles in Human Acute Monocytic Leukemia Cell Line (THP-1)